Mukka Proteins

Which are the latest news on Mukka Proteins?

Why is Mukka Proteins Ltd falling/rising?

As of 05-Sep, Mukka Proteins Ltd's stock price is rising to Rs. 31.33, up 9.32%, driven by strong financial performance, consecutive gains, and increased investor interest. The stock has outperformed its sector and reached a new 52-week high, indicating robust market sentiment.

As of 05-Sep, Mukka Proteins Ltd's stock price is rising, currently at Rs. 31.33, reflecting a change of 2.67 (9.32%) upward. This increase can be attributed to several positive factors. The stock has recently outperformed the sector by 8.98% and has been on a consecutive gain streak for the last four days, accumulating a remarkable 26.79% return during this period. Additionally, the stock opened with a gain of 3.98% today and reached a new 52-week high of Rs. 32.4, indicating strong investor interest.<BR><BR>The company's financial performance has also been robust, with net sales growing by 28.65% and positive results reported for the last three consecutive quarters. The profit before tax (PBT) has shown significant growth of 121.9%, while profit after tax (PAT) increased by 46.0%. Furthermore, the stock is trading above its moving averages across various time frames, suggesting a strong upward trend.<BR><BR>Investor participation has increased, as evidenced by a delivery volume rise of 358.09% compared to the five-day average, indicating heightened interest in the stock. Overall, these factors contribute to the stock's rising price, reflecting strong market sentiment and positive financial indicators.

What does Mukka Proteins do?

Mukka Proteins Ltd, a micro-cap company in the FMCG sector, was incorporated in 2003 and reported net sales of 490 Cr and a net profit of 19 Cr for June 2026. Key metrics include a P/E ratio of 11.00 and a market cap of INR 762 Cr.

Overview:<BR>Mukka Proteins Ltd operates in the FMCG industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Mukka Proteins Limited was originally incorporated as "Mukka Sea Food Industries" in Karnataka on March 13, 2003. It transitioned from a partnership firm to a private company named "Mukka Sea Food Industries Private Limited" on November 04, 2010. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 490 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 19 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 762 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00 <BR>Industry P/E: 19 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.44 <BR>Return on Equity: 10.37% <BR>Price-to-Book: 1.51 <BR><BR>Contact Details:<BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are the peers of the Mukka Proteins?

Mukka Proteins' peers include HMA Agro Inds., Vadilal Enterp., Lotus Chocolate, Sheetal Cool, Euro India Fresh, Freshara Agro, and Proventus Agro. Mukka Proteins has below-average management risk and growth, with a 1-year return of -7.21%.

Peers: The peers of Mukka Proteins are HMA Agro Inds., Vadilal Enterp., Lotus Chocolate, Sheetal Cool, Euro India Fresh, Freshara Agro, and Proventus Agro.<BR><BR>Quality Snapshot: Excellent management risk is observed at Vadilal Enterp. and Freshara Agro, while Average management risk is found at HMA Agro Inds., Lotus Chocolate, Sheetal Cool, and the rest. Below Average management risk is noted for Mukka Proteins, Euro India Fresh, and Proventus Agro. Growth is Excellent at Vadilal Enterp. and Freshara Agro, while Below Average growth is seen at HMA Agro Inds., Lotus Chocolate, Mukka Proteins, and the rest. Good growth is reported for Proventus Agro, while Below Average growth is noted for Sheetal Cool and Euro India Fresh. Capital Structure is Excellent at Proventus Agro, Good at Vadilal Enterp., Average at Sheetal Cool, and Below Average for HMA Agro Inds., Lotus Chocolate, Mukka Proteins, Euro India Fresh, and Freshara Agro.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sheetal Cool at 159.10%, while the lowest is HMA Agro Inds. at -30.38%. Mukka Proteins has a 1-year return of -7.21%, which is higher than HMA Agro Inds. but lower than Sheetal Cool. Additionally, Euro India Fresh and Freshara Agro have a six-month return of 0.00%.

How big is Mukka Proteins?

As of 31st August, Mukka Proteins Ltd has a market capitalization of 762.00 Cr, with recent net sales of 1768.34 Cr and a net profit of 69.14 Cr.

As of 31st August, Mukka Proteins Ltd has a market capitalization of 762.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Mukka Proteins reported Net Sales of 1768.34 Cr and a Net Profit of 69.14 Cr.<BR><BR>The latest reporting period for the balance sheet is March 2026, with Shareholder's Funds amounting to 499.09 Cr and Total Assets of 1,620.75 Cr.

Should I buy, sell or hold Mukka Proteins Ltd?

Are Mukka Proteins Ltd latest results good or bad?

Mukka Proteins Ltd's latest results are concerning, showing a 41.76% decline in Q4 FY26 net sales compared to the previous quarter, despite a 51.73% year-on-year increase in net profit. The company's heavy reliance on non-operating income and significant revenue volatility raise doubts about its long-term sustainability.

Mukka Proteins Ltd's latest results present a mixed picture, leaning more towards the negative side due to significant operational challenges. In Q4 FY26, the company reported net sales of ₹380.61 crores, which reflects a drastic decline of 41.76% compared to the previous quarter and a slight decrease of 0.25% year-on-year. This sharp drop follows an exceptional performance in Q3 FY26, where sales surged by 167.19%, indicating considerable volatility in revenue generation.<BR><BR>On the positive side, the consolidated net profit for Q4 FY26 was ₹20.62 crores, marking a year-on-year increase of 51.73%. The operating profit margin, excluding other income, improved to 9.21%, up from 7.84% in the same quarter last year. However, the company's heavy reliance on non-operating income, which constituted over 52% of profit before tax, raises concerns about the sustainability of these profit figures.<BR><BR>Overall, while there are some improvements in profitability metrics, the severe revenue volatility and negative operating cash flow—reported at ₹111 crores for FY25—highlight significant underlying issues. The stock has also underperformed compared to its peers and the broader FMCG sector, reflecting investor skepticism regarding its ability to deliver consistent value. Therefore, the latest results can be considered more concerning than encouraging.

When is the next results date for Mukka Proteins Ltd?

The next results date for Mukka Proteins Ltd is 15 May 2026.

The next results date for Mukka Proteins Ltd is scheduled for 15 May 2026.

Is Mukka Proteins technically bullish or bearish?

As of December 3, 2025, Mukka Proteins is in a mildly bearish trend, supported by bearish daily moving averages and Bollinger Bands, despite some mixed signals from the MACD and RSI across different timeframes.

As of 3 December 2025, the technical trend for Mukka Proteins has changed from sideways to mildly bearish. The current stance is bearish, with key indicators supporting this view. The daily moving averages are bearish, and both the weekly and monthly Bollinger Bands are also bearish. Although the weekly MACD and KST are mildly bullish, the overall sentiment is tempered by the bearish signals from the moving averages and Bollinger Bands. The RSI shows no signal on the weekly timeframe, while it is bullish on the monthly, indicating mixed signals across different timeframes. Overall, the bearish trend is currently stronger, reflecting the recent price decline from the previous close.

Is Mukka Proteins overvalued or undervalued?

As of November 14, 2025, Mukka Proteins is considered very attractive and undervalued with a PE ratio of 16.74 and an EV to EBITDA of 12.74, outperforming peers like Avanti Feeds and Apex Frozen Foods, and has delivered an 8.16% return compared to the Sensex's 1.62%.

As of 14 November 2025, Mukka Proteins has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued, supported by a PE ratio of 16.74, an EV to EBITDA ratio of 12.74, and a PEG ratio of 0.00, indicating strong potential for growth relative to its price. <BR><BR>In comparison with peers, Avanti Feeds has a PE ratio of 16.54 and an EV to EBITDA of 10.04, while Apex Frozen Foods shows a significantly higher PE ratio of 43.53, suggesting that Mukka Proteins is positioned favorably within its industry. Additionally, the company's recent stock performance has outpaced the Sensex over the past week, with an 8.16% return compared to the Sensex's 1.62%, reinforcing the notion of its undervaluation.

How has been the historical performance of Mukka Proteins?

Mukka Proteins has shown fluctuating performance, with net sales declining to 1,006.42 Cr in March 2025 from 1,379.83 Cr in March 2024, alongside decreases in profitability, while total assets increased to 1,076.32 Cr. The company faced a challenging year marked by negative cash flow and reduced profits.

Answer:<BR>The historical performance of Mukka Proteins shows a fluctuating trend in net sales and profitability over the years, with a notable decline in the most recent fiscal year.<BR><BR>Breakdown:<BR>Mukka Proteins reported net sales of 1,006.42 Cr for the year ending March 2025, a decrease from 1,379.83 Cr in March 2024 and 1,177.12 Cr in March 2023, but an increase from 770.50 Cr in March 2022. Total operating income mirrored this trend, reaching 1,006.42 Cr in March 2025. The company's total expenditure, excluding depreciation, was 911.53 Cr in March 2025, down from 1,274.36 Cr in March 2024, while operating profit (PBDIT) was 110.01 Cr, showing a decline from 121.79 Cr in the previous year. Profit before tax also decreased to 59.20 Cr in March 2025 from 84.35 Cr in March 2024. Consequently, profit after tax fell to 47.03 Cr from 71.20 Cr. The company's total assets increased to 1,076.32 Cr in March 2025, up from 940.79 Cr in March 2024, and total liabilities also rose to 1,076.32 Cr from 940.79 Cr. Cash flow from operating activities remained negative at -111.00 Cr in March 2025, although cash and cash equivalents decreased to 3.00 Cr from 94.00 Cr in March 2024. Overall, Mukka Proteins experienced a challenging year with declining sales and profits, despite an increase in total assets and liabilities.

Who are the top shareholders of the Mukka Proteins?

The top shareholders of Mukka Proteins include Mohammed Haris K, who holds 30.23%, followed by 7 Foreign Institutional Investors with 2.63%, and Neomile Growth Fund - Series I with 1.98%. Individual investors own 19.85%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Mukka Proteins include the promoters, who hold the majority of the shares. The promoter with the highest holding is Mohammed Haris K, who owns 30.23% of the company. Additionally, there are 7 Foreign Institutional Investors (FIIs) holding a combined 2.63% of the shares. The highest public shareholder is Neomile Growth Fund - Series I, which holds 1.98%. Individual investors collectively own 19.85% of the company. There are no pledged promoter holdings, and no mutual funds are currently invested in Mukka Proteins.

Has Mukka Proteins declared dividend?

No Dividend History Available